These findings indicated that enhanced apoptosis induced by combined treatment with vorinostat and gefitinib was partially dependent on inhibiting autophagy in EGFR-TKI-resistant NSCLC cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.